(Q40882180)

24 September 2017

Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer (English)

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

3 April 2023

1 reference

Merigan TC

1

1 reference

24 September 2017

Rand KH

2

1 reference

24 September 2017

Pollard RB

3

1 reference

24 September 2017

Abdallah PS

4

1 reference

24 September 2017

Jordan GW

5

1 reference

24 September 2017

Fried RP

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 1978

1 reference

24 September 2017

4 May 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=347294

full work available at URL

3 April 2023

http://www.nejm.org/doi/pdf/10.1056/NEJM197805042981801

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

The New England Journal of Medicine

3 April 2023

published in

1 reference

24 September 2017

298

1 reference

24 September 2017

981-987

1 reference

24 September 2017

18

1 reference

Inhibition of respiratory virus infection by locally applied interferon

24 September 2017

2

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Topical therapy of ulcerative herpetic keratitis with human interferon

3 April 2023

3

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

3 April 2023

4

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Interferon, antibody, and other host factors in herpes zoster

3 April 2023

5

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial

3 April 2023

6

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Multiplicity-dependent Replication of Varicella-zoster Virus in Interferon-treated Cells

3 April 2023

7

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection

3 April 2023

8

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

ACTION OF ENDOGENOUS INTERFERON AGAINST VACCINIA INFECTION IN CHILDREN

3 April 2023

9

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

3 April 2023

10

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Human Interferon Therapy for Herpes Zoster in Adults

3 April 2023

11

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Suppression of Mouse Antibody Producing Spleen Cells by Various Interferon Preparations

3 April 2023

12

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Immunosuppressive effects of an interferon preparation in vivo

3 April 2023

13

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Delayed-Type Hypersensitivity to Sheep Red Blood Cells: Inhibition of Sensitization by Interferon

3 April 2023

14

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS

3 April 2023

19

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Segmental zoster paresis--a disease profile

3 April 2023

20

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

A viremic phase for herpes zoster in children with cancer

3 April 2023

21

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)

3 April 2023

22

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

3 April 2023

23

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

3 April 2023

24

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study

3 April 2023

25

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Production of high-titered interferon in cultures of human diploid cells

3 April 2023

26

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

Production of Human Lymphoblastoid Interferon

3 April 2023

27

1 reference

https://api.crossref.org/works/10.1056/NEJM197805042981801

3 April 2023

Identifiers

1 reference

24 September 2017

1 reference